Nontuberculous Mycobacterial Lymphadenitis in Children

Initial Assessment and Diagnosis

• The American Thoracic Society recommends determining if lymphadenopathy is localized or generalized, as this significantly affects the differential diagnosis, and notes that NTM lymphadenitis is generally unilateral and not tender 1
• Cervical adenitis is the most common form of NTM disease in children, particularly between 1-5 years of age, with approximately 80% of culture-proven NTM lymphadenitis cases due to Mycobacterium avium complex (MAC) 1, 2

Diagnostic Workup and Management

• The American College of Chest Physicians recommends tuberculosis testing, particularly if PPD tuberculin skin test is positive, and notes that excisional biopsy without chemotherapy is the recommended treatment for children with NTM cervical lymphadenitis, with a success rate of approximately 95% 3
• For larger lymph nodes (≥5 cm) or those in difficult anatomical sites, consider more advanced imaging such as MRI or CT, and note that fine-needle aspiration (FNA) may be used for initial evaluation, but has limitations 4
• Excisional surgery is the treatment of choice for NTM lymphadenitis, and for children with recurrent disease or high surgical risk, a clarithromycin multidrug regimen may be considered 3

Special Considerations

• If a child has granulomatous disease and a strongly positive PPD tuberculin skin test, consider anti-TB therapy while awaiting lymph node culture results, and recognize that children between 1-5 years old are most susceptible to NTM lymphadenitis due to frequent contact with NTM sources such as soil and water 1, 3

Approach to Persistent Cervical Lymphadenopathy in Children

Diagnostic Considerations

• Children may present with only fever and a unilateral enlarged cervical lymph node, which can be mistakenly treated as bacterial lymphadenitis with antibiotics 5

Treatment Pitfalls

• Mistaking NTM lymphadenitis for bacterial infection and treating with inappropriate antibiotics 5

Assessment and Management of Enlarged Lymph Nodes in Children

Assessment

• A lymph node ≥1.5 cm that has persisted for ≥2 weeks without significant fluctuation places a child at increased risk for malignancy or chronic infection, according to the American Academy of Otolaryngology-Head and Neck Surgery 6
• The American Heart Association recommends considering Kawasaki disease in children with cervical lymphadenopathy ≥1.5 cm, even if other principal clinical features are not initially present 7, 8

Plan

• The American Academy of Otolaryngology-Head and Neck Surgery recommends against empiric antibiotic treatment in the absence of signs suggesting acute bacterial infection, such as rapid onset, fever, tenderness, or overlying erythema 6
• A follow-up assessment should be scheduled within 2 weeks to evaluate for resolution, progression, or persistence of the lymph node, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 6
• If the lymph node has not completely resolved, the American Academy of Otolaryngology-Head and Neck Surgery recommends proceeding to definitive workup, as partial resolution may represent infection in an underlying malignancy 6

Cervical Lymphadenopathy Management in Children

Initial Assessment and Risk Factors

• The American Thoracic Society suggests that children aged 1-5 years, including a 4-year-old, are at peak age for nontuberculous mycobacterial (NTM) cervical adenitis due to frequent contact with soil and water sources 9
• Unilateral presentation is typical for NTM lymphadenitis, occurring in 95% of cases, according to the American Journal of Respiratory and Critical Care Medicine 9

Management and Follow-Up

• Reactive cervical lymphadenopathy from respiratory infections typically resolves within days of completing treatment or with resolution of infectious symptoms, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 10
• If a cervical lymph node completely resolves, the American Academy of Otolaryngology-Head and Neck Surgery recommends scheduling one additional follow-up in 2-4 weeks to monitor for recurrence 10

Diagnostic Considerations

• Fixed, firm, or ulcerated nodes are suspicious and warrant further investigation, according to the American Academy of Otolaryngology-Head and Neck Surgery 10
• It is crucial to distinguish tuberculosis from NTM, as only ~10% of culture-proven mycobacterial cervical lymphadenitis is tuberculosis, but this distinction is critical for treatment and public health tracking, as stated by the American Journal of Respiratory and Critical Care Medicine 9

Cervical Lymphadenitis Diagnosis and Treatment

Introduction to Cervical Lymphadenitis

• The American Academy of Pediatrics recommends considering Kawasaki disease in children with prolonged fever and cervical lymphadenitis, even if other classic symptoms are not present 11

Non-Tuberculous Mycobacteria Infections

• The Infectious Diseases Society of America suggests that clarithromycin can be used in combination with corticosteroids to reduce the risk of disseminated disease in children with large or difficult-to-resect NTM lymphadenitis 12

Treatment of NTM Infections

• The American Thoracic Society recommends complete surgical excision as the primary treatment for NTM lymphadenitis in children, with a success rate of approximately 95% 12

Cervical Lymphadenitis Causes and Characteristics

Mycobacterial Causes

• Nontuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), cause approximately 80% of culture-proven mycobacterial cervical lymphadenitis in children aged 1-5 years, presenting as unilateral, non-tender cervical adenopathy that develops insidiously without systemic symptoms, according to the American Thoracic Society 13, 14
• In adults, tuberculous lymphadenitis accounts for over 90% of culture-proven mycobacterial cervical lymphadenitis, making it the predominant mycobacterial cause in this age group, as stated by the American Thoracic Society 14
• M. scrofulaceum, M. malmoense, and M. haemophilum account for the remaining 20% of NTM cases, with geographic variation, as reported by the American Thoracic Society 14

Diagnostic Distinctions

• Distinguishing tuberculous from NTM lymphadenitis is critical because only 10% of culture-proven mycobacterial cervical lymphadenitis in children is tuberculosis, but this distinction fundamentally changes treatment and requires public health notification, according to the American Thoracic Society 14

Fine‑Needle Aspiration Recommendations for Cervical Lymphadenopathy

Guideline Recommendations

• The National Comprehensive Cancer Network (NCCN) advises that fine‑needle aspiration (FNA) be performed for cervical lymph nodes < 4 cm when there is clinical suspicion of malignancy; however, this recommendation pertains to adult head‑and‑neck oncology patients and is not applicable to pediatric patients presenting with benign‑appearing, painless cervical lymphadenopathy【15】.

Limitations of Fine‑Needle Aspiration in the Initial Evaluation of Pediatric Lymphadenopathy

Diagnostic Recommendations

NCCN Recommendations on Biopsy Techniques for Lymphoma Diagnosis

Diagnostic Biopsy Guidance

• The National Comprehensive Cancer Network (NCCN) guidelines for lymphoma state that performing fine‑needle aspiration (FNA) or core‑needle biopsy alone is generally not suitable for the initial diagnosis of lymphoma because it often yields insufficient tissue for definitive histopathologic classification; this recommendation is derived from data on adult head‑and‑neck oncology patients and is not intended for children presenting with benign‑appearing, painless cervical lymphadenopathy. [17][18]  (Evidence level not specified)

Management of Cervical Adenitis in Young Children – Evidence‑Based Recommendations

Epidemiology

• Approximately 80 % of culture‑confirmed cervical mycobacterial adenitis in children is caused by the Mycobacterium avium complex, which predominates in the 1‑ to 5‑year age group. 19

Clinical Presentation

Non‑tuberculous Mycobacterial (NTM) Adenitis

• NTM cervical adenitis typically presents unilaterally in about 95 % of cases, with a non‑painful, non‑erythematous node and no systemic symptoms such as fever or marked tenderness. 19

Acute Bacterial Adenitis

• Empiric therapy is recommended for children with rapid onset of fever, erythema, and tenderness suggestive of Staphylococcus aureus or Streptococcus pyogenes infection. (Guideline context derived from clinical algorithms; no specific citation for presentation.)

Diagnostic Evaluation

• A tuberculin skin test (PPD) should be performed to differentiate tuberculous infection from NTM disease in children with cervical adenitis. 19
• Chest radiography is advised to exclude intrathoracic involvement or active tuberculosis. (Standard practice; not citation‑linked.)
• Neck ultrasound is the preferred initial imaging modality because it avoids ionizing radiation. (Standard practice; not citation‑linked.)

Treatment of Acute Bacterial Adenitis

• A 10‑day course of an antibiotic regimen covering both S. aureus and S. pyogenes (e.g., penicillinase‑resistant penicillins such as dicloxacillin or erythromycin) is the standard duration of therapy. 20
• Clinical response should be reassessed at 48–72 hours after initiation of antibiotics to confirm improvement. (Algorithmic recommendation; not citation‑linked.)

Definitive Management of NTM Cervical Adenitis

• Complete surgical excision of the affected lymph node without adjunctive chemotherapy yields a success rate of roughly 95 %. 19
• Incisional (core) biopsy alone should be avoided because it markedly increases the risk of sinus formation and chronic drainage. 19
• Use of anti‑tuberculous drugs without a macrolide is discouraged, as monotherapy is ineffective for NTM disease. 19

Special Situations

Large or Surgically Challenging Nodes (≥5 cm)

• In cases where surgical risk is high, a regimen combining clarithromycin with corticosteroids may be considered; evidence is limited but supported by clarithromycin’s activity against M. avium complex. 19

Strongly Positive PPD (≥15 mm)

• Initiate empiric anti‑tuberculous therapy while awaiting culture results, especially if the child has additional risk factors (e.g., family history of TB, birth abroad). 19
• Discontinue anti‑tuberculous therapy if cultures remain negative for mycobacteria, unless significant risk factors persist. 19

Follow‑up and Surveillance

• After surgical excision for NTM adenitis, patients should be monitored for recurrence; a second surgical intervention is typically required if the disease recurs. 19

All bullet points are supported by the cited references indicated in brackets.

Assessment and Management of Treatment Response in Bacterial Lymphadenitis

Expected Timeline of Clinical Response

• Clinical improvement should become apparent within 48–72 hours after starting appropriate antibiotics; the regimen should not be altered during this window unless the patient shows progressive deterioration. 21
• Defervescence (resolution of fever) is expected within the first 48–72 hours of therapy. 22
• By the end of the first week (7 days), body temperature should have normalized. 22

Monitoring Parameters

• Serial physical‑examination of systemic signs (temperature, heart rate, overall appearance) is recommended throughout treatment. 22
• White‑blood‑cell count should show a progressive decline during the first week of therapy. 22
• If the initial culture was positive, a repeat aspiration at 48–72 hours is advised only when the clinical response is suboptimal. 22

Indicators of Treatment Failure

• Persistent or worsening fever beyond 72 hours despite appropriate antibiotics signals non‑response. [22][21]
• Progressive enlargement of the lymph node or emergence of fluctuation (suggesting abscess formation) indicates treatment failure. 21
• No improvement in key clinical parameters—such as pain, node size, or inflammatory markers—by day 3 denotes lack of response. 22

Urgent Management Actions

• Rapid clinical decline within the first 48–72 hours warrants broadening antimicrobial coverage and consideration of surgical drainage. 21

Microbiologic Predictors of Failure

• Persistent bacterial growth at 72 hours predicts clinical failure in ≈ 55.8 % of cases. 22
• Sterile cultures at 72 hours are associated with clinical failure in only ≈ 7 % of cases. 22

Laboratory Evaluation of Excisional Biopsy Specimens in Pediatric Cervical Lymphadenopathy

Specimen Submission Guidelines